BMY vs VHI · P/E 17, rev $24.46B vs rev $2.10B
Bristol-Myers Squibb Company (BMY) versus Valhi Inc (VHI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Valhi Inc (VHI) is a chemicals company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported VHI revenue for 2024-12-31 was $2.10B. Net income was $161.3M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VHI currently screens at market cap $399.3M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. VHI currently screens at market cap $399.3M.
Not investment advice. Open the BMY and VHI stock pages for the full models.
Not investment advice.